Clinical Studies

Are you looking for a solution that may reduce or eliminate your need to carry magnifiers with you everywhere?

If you have AMD, you may be eligible to participate in this research study.

Now is a great time to schedule a free evaluation. For more information or to later set up an appointment, please call 949-842-9954 or email nedwards@onpoint-vision.com

You may be a candidate if:

  • You have AMD in both eyes.
  • You are 55 years or older.
  • You do not have cognitive impairment that may interfere with your ability to make an informed decision.
  • You have had previous cataract surgery at least 6-months ago.
  • You do not have glaucoma.
  • You have no acute chronic or systemic health issues (i.e., diabetes)
  • You do not drive at night.
MORE INFORMATION

OnPoint Vision is collaborating with 4 Clinical Centers of Excellence for patients with Age Related Macular Degeneration otherwise known as AMD to improve your near vision. 2 are located in Southern California, 1 in Fort Worth, Texas, and 1 in Eugene, Oregon. The Clinical Investigators chosen to participate in this study are renowned physicians and leaders in the ophthalmic community.

To discuss participating in our clinical study we are providing a no charge evaluation. We encourage you to contact the phone number nearest to your location. 

Inland Eye Specialists

3953 W. Stetson Avenue
Hemet, CA. 92543

Principal Investigator: Robert Sorenson, M.D., Ph.D.

www.inlandeyespecialists.com

Contact: Jazmin Ponce, Clinical Coordinator at 951-492-4205 or Natalie Edwards Sr. Clinical Application Specialist at 949-842-9954 to discuss a “no charge” evaluation

Gordon Schanzlin New Vision Institute

4130 La Jolla Village Drive
Suite 300
San Diego, CA. 92037

Principal Investigator: Julio Echegoyen, M.D., Ph.D.

www.gwsvision.com

Contact:  Natalie Edwards, Sr. Clinical Application Specialist at 949-842-9954 to discuss a “no charge” evaluation

Star Retina

2780 S. W. Wilshire Blvd.
Burleson, TX 76028

Principal Investigator: Courtney Crawford, M.D.

www.starretina.com

Contact: Mikki Sells, Study Coordinator at 817-378-4777  or Monica Orlofski, Clinical Application Specialist
214-683-8592 to discuss a “no charge” evaluation

Verum Research LLC - Sterling Vision PC

1011 Valley River Way
Suite 110
Eugene, OR 97401

Principal Investigator: Albert Edwards, M.D., Ph.D.

www.verumresearch.com

Contact: Natalie Kogutkeiwicz, Clinical Coordinator at 541-255-1492  or Monica Orlofski, Clinical Application Specialist at 214-683-8592 to discuss a “no charge” evaluation

KEVIN CADY
President & CEO

Kevin Cady is the CEO and Founder of OnPoint Vision™, a refractive company that designs, develops & manufactures intraocular lens implants, most specifically the AccuraSee™ Intraocular Pseudophakic Contact Lens (AKA: CadyLens) designed to fine-tune the refractive error of the pseudophakic eye as well as deliver vision recovery for patients who have experienced a decline in vision due to age-related retinal pathologies.  Prior to forming OnPoint Vision™, Mr. Cady joined Refocus Group in 2015 as Vice President of Marketing & Business Development. From 2011 to 2014, Mr. Cady was the Regional Business Director for WaveTec Vision Systems, where he was responsible for the marketplace expansion of the Optiwave Refractive Analysis (ORA) system to ophthalmic surgeons. Prior to joining WaveTec Vision Systems, Mr. Cady was the Area Vice President of Sales for Bausch Lomb Surgical, after the company acquired Eyeonics. Mr. Cady has over 30 years in the ophthalmic industry theatre with extensive knowledge and experience in both the development of ophthalmic pharmacologic agents and medical device product line.

Mr. Cady has a Bachelor of Science Degree in Economics from Illinois State University. He is credentialed with over 35 patents worldwide with the  invention of the CadyLens, an Intraocular Pseudophakic Contact Lens (IOPCL) as well as related surgical instruments and medical devices.